7th November 2016
Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.
Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.
Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.
Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”
16th May 2017
Unveiling life-changing technology
Mobile health startup, Mindstrong Health has selected Grayling to help emerge from stealth mode and begin garnering business, tech, and trade media coverage of its breakthrough technology. The young...Read More
28th April 2017
Colombian Energy Giant Appoints Grayling for IR Brief
International communications agency, Grayling has been appointed to to conduct a peer and benchmarking analysis for Empresa de Energia de Bogota (EEB), one of the leading energy groups in Colombia....Read More
27th March 2017
Morrow Sodali retains Grayling
Global corporate governance consultancy and proxy solicitation firm, Morrow Sodali has appointed Grayling, with a brief to improve the company’s visibility among the capital markets as it seeks to...Read More